Stroke in Patients With Unresectable Pancreatic Cancer Undergoing Chemotherapy: Clinical Characteristics and Risk Assessment
Stroke within 180 days occurred in 3.2% of patients and was commonly associated with discontinuation of chemotherapy and short survival. The combined score calculated with D-dimer and CA 19-9 levels predicted the stroke risk in pancreatic cancer patients receiving chemotherapy.
Authors
- Hirokazu Mouri
- Hidenobu Hata
- Yosuke Uenishi
- Toshifumi Mano
- Yuki Ikeda (ORCID: https://orcid.org/0000-0002-7371-8326)
- Takafumi Kanadani
- Yutaka Akimoto (ORCID: https://orcid.org/0000-0002-9807-6542)
- Ayako Togawa
- Yoko Ishihara (ORCID: https://orcid.org/0000-0003-3269-0803)
- Etsuji Ishida
- Ayako Hata
- Masayuki Ueno (ORCID: https://orcid.org/0000-0002-2497-9327)
- Motowo Mizuno (ORCID: https://orcid.org/0000-0001-6974-4401)
- Toshikazu Moriwaki (ORCID: https://orcid.org/0000-0001-7702-122X)
Institutions
- Kyoto University (JP)
- Kurashiki Central Hospital (JP)
- Okayama Red Cross General Hospital (JP)
Publication Details
- Journal
- Pancreas
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1097/mpa.0000000000002555
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00